SIGA Technologies Stock (NASDAQ:SIGA), Trade Ideas

SIGA Technologies

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACON

ACOR

ADTX

ALLG

ASTS

AVTX

AWIN

CIFR

CISS

CLSK

CXAI

DCFC

GCTS

GOEV

GRTS

GUTS

JZXN

LIFW

MSTR

MVST

ORGS

PPSI

PTPI

QDEL

SIGA

SNAX

TPET

VERV

VTSI

VVPR

XTIA

YTEN

Shares of  Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

EXAS

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

TCOM

VNET

U.S. stocks were lower, with the Dow Jones falling around 400 points on Tuesday.

ChampionX, Montrose Environmental Group And Other Big Stocks Moving Higher On Tuesday

ADTH

AIRE

ANNX

ATER

BGNE

BIRD

BTOG

CLOV

CMTL

DLTR

ECDA

EDUC

GXAI

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HRTX

Kintara Therapeutics, Inc. - Common Stock

KTRA

LICY

LUNA

MINM

MNMD

NAAS

NATR

NCNA

NMRA

PIII

PRTG

RXRX

SKIN

SMMT

SURG

SWIN

VERI

VJET

Shares of  Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

SIGA Technologies Inc

<a href="https://www.the-sun.com/health/11114810/mutant-monkeypox-mpox-pandemic-potential/">https://www.the-sun.com/health/11114810/mutant-monkeypox-mpox-pandemic-potential/</a>
&nbsp;
&nbsp;

Rumors

Analyst Ratings

Watching SIGA Technologies; Traders Circulate The U.S. Sun Article Saying "A Mutant Strain Of Mpox With "New Pandemic Potential" Has Been Discovered In A Small Town In The Democratic Republic Of Congo, According To Research."

<a href="https://twitter.com/DrTedros/status/1778423967105139108">https://twitter.com/DrTedros/status/1778423967105139108</a>
&nbsp;
&nbsp;

Biotech

Global

General

AEMD

CMRX

GOVX

MRNA

TNXP

WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC alone, more than 4500 cases of #mpox and almost 300 deaths have been reported this year. That is triple the number reported at this time last year. The recent surge in cases and deaths among children is of particular concern, along with the re-emergence of Clade One in central Africa...."

Shares of Stryve Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snax#NASDAQ">SNAX</a>) fell sharply during Tuesday&rsquo;s session following a <a href="https://www.benzinga.com/quote/SNAX/earnings">fourth-quarter revenue miss.</a>
Stryve Foods posted adjusted loss of $1.90 per share, versus market estimates for a loss of $1.96 per share. The company&rsquo;s sales came in at $2.887 million versus expectations of $5.009 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Stryve Foods shares dipped 25.2% to $1.0965 on Tuesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>VivoPower International PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvpr#NASDAQ">VVPR</a>) shares surged 315% to $6.10 after the company&#39;s Tembo subsidiary announced it will merge with the Nasdaq-listed Cactus Acquisition Corp. 1 Limited.</li>
<li>Trio Petroleum Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpet#NYSE">TPET</a>) gained 73.8% to $0.1797 after jumping over 21% on Monday.</li>
<li>XTI Aerospace, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xtia#NASDAQ">XTIA</a>) rose 63.9% to $3.3750 after jumping 19% on Monday.</li>
<li>Kidpik Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pik#NASDAQ">PIK</a>) shares climbed 35.2% to $5.90 after the company entered a merger agreement with Nina Footwear.</li>
<li>VirTra, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtsi#NASDAQ">VTSI</a>) rose 32.8% to $12.67 after the company reported better-than-expected fourth-quarter results.</li>
<li>MSP Recovery, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lifw#NASDAQ">LIFW</a>) gained 26.9% to $0.8449 after a 13G filing showed Palantir Technologies reported a 6.5% stake in the company as of March 22, 2024.</li>
<li>Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) gained 20% to $3.8204 after the company announced it will acquire Appili Therapeutics.</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) climbed 18.1% to $1.70.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) rose 18% to $0.0426.</li>
<li>Nexalin Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxl#NASDAQ">NXL</a>) gained 18% to $2.2400. Nexalin Technology announced the appointment of Government Affairs Veteran William A. Hudson, Jr. to Military &amp; Government Advisory Board.</li>
<li>Concord Medical Services Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccm#NYSE">CCM</a>) rose 17.7% to $0.6119.</li>
<li>Jiuzi Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jzxn#NASDAQ">JZXN</a>) gained 10.7% to $4.43.</li>
<li>Yatsen Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ysg#NYSE">YSG</a>) rose 10% to $2.52.</li>
<li>ChampionX Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chx#NASDAQ">CHX</a>) gained 9.5% to $38.78 after SLB announced it will acquire the company.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) rose 8.2% to $8.15.</li>
<li>SIGA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/siga#NASDAQ">SIGA</a>) gained 7.4% to $9.45. SIGA Technologies entered amendment to its international promotion agreement with Meridian Medical.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Acorda Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) shares dipped 83.5% to $2.1999 after the company commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.</li>
<li>Gritstone bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grts#NASDAQ">GRTS</a>) dipped 47% to $1.2450 after the company announced a $32.5 million underwritten public offering of 8,333,333 shares of common stock and accompanying common warrants at $1.50 per share and accompanying common warrant.</li>
<li>Orgenesis Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/orgs#NASDAQ">ORGS</a>) fell 39.8% to $0.3499.</li>
<li>Verve Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verv#NASDAQ">VERV</a>) dipped 37.7% to $7.96 amid the company pausing enrollment in its Heart-1 Phase 1b clinical trial after a participant experienced a Grade 3 drug-induced transient increase in serum alanine aminotransferase as well as a serious adverse event.</li>
<li>Microvast Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mvst#NASDAQ">MVST</a>) fell 32.1% to $0.6078 after announcing fourth-quarter financial results.</li>
<li>Binah Capital Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcg#NASDAQ">BCG</a>) dipped 31.2% to $7.11.</li>
<li>Canoo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goev#NASDAQ">GOEV</a>) fell 28.7% to $2.7593 after the company issued weak 2024 revenue guidance.</li>
<li>CXApp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxai#NASDAQ">CXAI</a>) declined 26.8% to $4.50, pulling back after the stock rallied on Monday following a Google Cloud partnership.</li>
<li>Pioneer Power Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ppsi#NASDAQ">PPSI</a>) fell 25.8% to $4.40 after reporting unaudited preliminary financial results for the fourth quarter and 12 months ended Dec. 31, 2023.</li>
<li>Petros Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ptpi#NASDAQ">PTPI</a>) fell 23.8% to $1.0650 following weak quarterly results.</li>
<li>Yield10 Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yten#NASDAQ">YTEN</a>) dipped 23.5% to $0.2933 following quarterly results.</li>
<li>PVH Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pvh#NYSE">PVH</a>) fell 23.3% to $107.19 after the company reported fourth-quarter financial results and issued guidance.</li>
<li>Aclarion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) shares tumbled 21.8% to $0.3205 after jumping 24% on Monday. Aclarion received a Notice of Allowance for its U.S. patent application 18/190,723 titled &quot;Magnetic Resonance Spectroscopy Pulse Sequence, Acquisition, And Processing System And Method (For Diagnosing Pain).&quot;</li>
<li>GCT Semiconductor Holding, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gcts#NASDAQ">GCTS</a>) shares fell 19.6% to $14.53 after declining over 45% on Monday. GCT Semiconductor appointed Nelson C. Chan to Board of Directors.</li>
<li>Allego N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/allg#NYSE">ALLG</a>) fell 18.4% to $1.25. Allego postponed fourth quarter And full year 2023 financial results conference call.</li>
<li>AST SpaceMobile, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asts#NASDAQ">ASTS</a>) declined 17.4% to $2.1724 after the company reported worse-than-expected fourth quarter EPS results.</li>
<li>Tritium DCFC Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcfc#NASDAQ">DCFC</a>) declined 15.5% to $8.50.</li>
<li>Cipher Mining Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cifr#NASDAQ">CIFR</a>) fell 15% to $4.15 amid a drop in Bitcoin.</li>
<li>Humana Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hum#NYSE">HUM</a>) shares fell 13.8% to $302.65 after the Centers for Medicare &amp; Medicaid Services (CMS) finalized payment updates. The CMS announced Monday that it finalized the calendar year 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) programs that updates payment policies for these programs and ensures payment accuracy.</li>
<li>AERWINS Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/awin#NASDAQ">AWIN</a>) declined 12.1% to $5.80.</li>
<li>Avalo Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avtx#NASDAQ">AVTX</a>) fell 11% to $15.93. Avalo Therapeutics shares fell around 18% on Monday after the company reported worse-than-expected FY23 EPS results.</li>
<li>Fractyl Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/guts#NASDAQ">GUTS</a>) shares dipped 10.7% to $6.64 amid volatility after the company reported fourth-quarter financial results.</li>
<li>HWH International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwh#NASDAQ">HWH</a>) shares fell 10.5% to $0.8450 after falling 5% on Monday.</li>
<li>agilon health, inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/agl#NYSE">AGL</a>) fell 9.6% to $5.28.</li>
<li>QuidelOrtho Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qdel#NASDAQ">QDEL</a>) fell 8.5% to $43.01. QuidelOrtho receives FDA clearance for QuickVue COVID-19 test.</li>
<li>CVS Health Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvs#NYSE">CVS</a>) shares declined 8.2% to $73.00 after the Centers for Medicare &amp; Medicaid Services (CMS) finalized payment updates.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) fell 7.9% to $17.11 amid a drop in Bitcoin.</li>
<li>RH (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rh#NYSE">RH</a>) fell 7.3% to $310.31. Goldman Sachs analyst Kate McShane maintained RH with a Sell and raised the price target from $201 to $264.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) shares declined 7.2% to $1,518.97 amid a decline in Bitcoin.</li>
<li>UnitedHealth Group Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unh#NYSE">UNH</a>) fell 7.2% to $454.44 on the heels of finalized payment updates from the Centers for Medicare &amp; Medicaid Services (CMS).</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38047904/bitcoin-falls-below-66-000-axelar-becomes-top-loser"> Bitcoin Falls Below $66,000; Axelar Becomes Top Loser </a>

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

U.S. stocks were lower, with the Dow Jones falling around 400 points on Tuesday.
Shares of ChampionX Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chx#NASDAQ">CHX</a>) rose sharply during Tuesday&rsquo;s session after Schlumberger Limited&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/slb#NYSE">SLB</a>) announced it will <a href="https://www.benzinga.com/quote/CHX">acquire the company</a>.
ChampionX shares jumped 9.5% to $38.78 on Tuesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>VirTra, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtsi#NASDAQ">VTSI</a>) shares jumped 32.8% to $12.67 after the company reported better-than-expected fourth-quarter results.</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) gained 18.1% to $1.70.</li>
<li>Jiuzi Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jzxn#NASDAQ">JZXN</a>) climbed 10.7% to $4.43.</li>
<li>Yatsen Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ysg#NYSE">YSG</a>) rose 10% to $2.52.</li>
<li>Exact Sciences Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exas#NASDAQ">EXAS</a>) gained 8.6% to $76.56.</li>
<li>VNET Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnet#NASDAQ">VNET</a>) gained 8.2% to $1.7850.</li>
<li>Montrose Environmental Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/meg#NYSE">MEG</a>) gained 8.4% to $42.73. Montrose Environmental Group acquired Engineering &amp; Technical Associates and raised 2024 revenue outlook.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) climbed 8.2% to $8.15.</li>
<li>SIGA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/siga#NASDAQ">SIGA</a>) rose 7.4% to $9.45. SIGA Technologies entered amendment to its international promotion agreement with Meridian Medical.</li>
<li>SunCar Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sda#NASDAQ">SDA</a>) gained 6.7% to $7.79. SunCar Technology Group announced it will offer exclusive airport concierge car services to the private banking clientele of China CITIC Bank International Limited.</li>
<li>Trip.com Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcom#NASDAQ">TCOM</a>) gained 3.5% to $48.58. Citigroup, on Monday, maintained a Buy rating on the stock and raised its price target from $53 to $55.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38047904/bitcoin-falls-below-66-000-axelar-becomes-top-loser"> Bitcoin Falls Below $66,000; Axelar Becomes Top Loser</a>

Effective June 1, SIGA will drive international promotion activities for oral TPOXX&nbsp;while maintaining its contractual relationship with Meridian to maintain continuity for key customer relationships.&nbsp;This amendment, which extends the term of the promotion agreement by two years with respect to specific territories including the European Union, gives SIGA primary responsibility for promoting oral TPOXX.&nbsp;Certain existing contracts under the promotion agreement, including Meridian&#39;s contract with the European Commission&#39;s DG&nbsp;Health Emergency Preparedness and Response Authority (HERA), will remain in effect.

SIGA Technologies Enters Amendment To Its International Promotion Agreement With Meridian Medical

Shares of Clover Health Investments, Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clov#NASDAQ">CLOV</a>) rose sharply during Wednesday&rsquo;s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.
Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 million by 6.26% and represents a 43.22% decrease over sales of $898.79 million the same period last year.
Clover Health Investments shares climbed 11.2% to $0.8537 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Gaxos.ai Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gxai#NASDAQ">GXAI</a>) shares jumped 128.9% to $12.18 after the company announced it acquired the rights to use certain AI-enabled technology from Ultiself.</li>
<li>Veritone, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veri#NASDAQ">VERI</a>) gained 52.4% to $2.6076 following strong sales results.</li>
<li>NuCana plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncna#NASDAQ">NCNA</a>) gained 50.2% to $0.5869 after the company was granted a US Patent for &quot;Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance.&quot;</li>
<li>The Beauty Health Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skin#NASDAQ">SKIN</a>) rose 31.9% to $4.7350 after the company reported better-than-expected fourth-quarter revenue results.</li>
<li>Arq, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arq#NASDAQ">ARQ</a>) gained 28.3% to $4.4522 after the company reported upbeat fourth-quarter results.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) jumped 26.6% to $6.19.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktra#NASDAQ">KTRA</a>) shares gained 26.2% to $0.1055.</li>
<li>Nature&#39;s Sunshine Products, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/natr#NASDAQ">NATR</a>) jumped 24.7% to $21.47 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 net sales guidance.</li>
<li>Heron Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hrtx#NASDAQ">HRTX</a>) gained 24.7% to $2.9428 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $4 to $5.</li>
<li>Li-Cycle Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/licy#NASDAQ">LICY</a>) shares gained 23.2% to $0.7233. Li-Cycle shares jumped 46% on Tuesday after the company entered an agreement to issue a senior secured convertible note in an aggregate principal amount of $75 million to an affiliate of Glencore.</li>
<li>Cue Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cue#NASDAQ">CUE</a>) gained 19.2% to $2.11 after Jefferies initiated coverage on the stock with a Buy rating and $6 price target.</li>
<li>AdTheorent Holding Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adth#NASDAQ">ADTH</a>) surged 19% to $3.4150 following strong sales.</li>
<li>SIGA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/siga#NASDAQ">SIGA</a>) gained 18.8% to $6.32 after the company reported a year-over-year increase in quarterly financial results.</li>
<li>Educational Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/educ#NASDAQ">EDUC</a>) surged 18.1% to $2.0432.</li>
<li>Portage Biotech Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prtg#NASDAQ">PRTG</a>) gained 17.7% to $0.6589.</li>
<li>Williams-Sonoma, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wsm#NYSE">WSM</a>) climbed 17.7% to $283.70 after the company reported better-than-expected fourth-quarter earnings, announced a new $ 1 billion stock repurchase authorization and increased its quarterly dividend.</li>
<li>HUTCHMED (China) Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcm#NASDAQ">HCM</a>) shares climbed 15.8% to $18.91 after gaining 9% on Tuesday.</li>
<li>Annexon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/annx#NASDAQ">ANNX</a>) rose 15% to $5.28. Needham analyst Joseph Stringer reiterated Annexon with a Buy and maintained a $16 price target.</li>
<li>Mind Medicine (MindMed) Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnmd#NASDAQ">MNMD</a>) gained 13.2% to $8.90.</li>
<li>Full Truck Alliance Co. Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ymm#NYSE">YMM</a>) climbed 11.2% to $7.74. Full Truck Alliance announced extension of share repurchase program up to $300 million.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) gained 10% to $4.7450.</li>
<li>Qilian International Holding Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qli#NASDAQ">QLI</a>) climbed 10% to $0.6052.</li>
<li>PBF Energy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pbf#NYSE">PBF</a>) gained 9.4% to $55.18.</li>
<li>BeiGene, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgne#NASDAQ">BGNE</a>) shares climbed 9% to $178.44.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) gained 8.3% to $5.43 after the company announced that it entered into a definitive merger agreement with e2Companies.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxrx#NASDAQ">RXRX</a>) rose 7% to $ 11.27.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>voxeljet AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vjet#NASDAQ">VJET</a>) shares fell 40.8% to $0.5922 after the company announced it will voluntarily delist its ADSs from Nasdaq and deregister its ADSs. The company also announced the restatement and extension of its loan financing with Anzu.</li>
<li>Luna Innovations Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/luna#NASDAQ">LUNA</a>) fell 39% to $3.82 after the company announced that it will delay the release of its fourth-quarter and FY23 financial results. and said financial statements for the quarters ended Jun. 30 and Sept. 30 should no longer be relied upon.</li>
<li>SurgePays, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/surg#NASDAQ">SURG</a>) fell 30.5% to $4.86 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>P3 Health Partners Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/piii#NASDAQ">PIII</a>) fell 29.4% to $0.72.</li>
<li>SOS Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sos#NYSE">SOS</a>) dipped 28% to $1.5399 G</li>
<li>Allbirds, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bird#NASDAQ">BIRD</a>) declined 25.3% to $0.6952 after the company reported worse-than-expected fourth-quarter GAAP EPS results.</li>
<li>Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) fell 23.3% to $0.5710.</li>
<li>WideOpenWest, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wow#NYSE">WOW</a>) fell 21.1% to $2.7290 after the company reported worse-than-expected fourth-quarter financial results and issued guidance.</li>
<li>NaaS Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/naas#NASDAQ">NAAS</a>) fell 20.1% to $1.19 after the company announced a $6 million registered direct offering.</li>
<li>Comtech Telecommunications Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmtl#NASDAQ">CMTL</a>) fell 19% to $4.6599. Comtech named John Ratigan as Interim Chief Executive Officer.</li>
<li>Aterian, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ater#NASDAQ">ATER</a>) tumbled 19% to $0.3783 following quarterly results.</li>
<li>Psyence Biomedical Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) fell 17.8% to $1.01.</li>
<li>reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) fell 16.3% to $1.07 after the company reported EPS for the eight months ended Dec. 31, 2023.</li>
<li>loanDepot, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ldi#NYSE">LDI</a>) fell 15.9% to $2.1350 following weak quarterly results.</li>
<li>Bit Origin Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btog#NASDAQ">BTOG</a>) fell 15.7% to $4.45 after gaining 11% on Tuesday.</li>
<li>Dollar Tree, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dltr#NASDAQ">DLTR</a>) declined 14.5% to $128.00 after the company reported worse-than-expected fourth-quarter financial results and issued first-quarter EPS guidance below estimates.</li>
<li>Rackspace Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rxt#NASDAQ">RXT</a>) dipped 13.3% to $1.9150 after the company issued first-quarter guidance below estimates. The company also announced refinancing transactions.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zim#NYSE">ZIM</a>) fell 12.4% to $10.22 following weak quarterly sales.</li>
<li>Neumora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmra#NASDAQ">NMRA</a>) declined 12.2% to $15.24.</li>
<li>ECD Automotive Design, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ecda#NASDAQ">ECDA</a>) dipped 10.8% to $1.07 after jumping over 13% on Tuesday.</li>
<li>Solowin Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swin#NASDAQ">SWIN</a>) fell 8.6% to $26.61.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/03/37657561/nvidia-to-rally-around-20-here-are-10-top-analyst-forecasts-for-wednesday"> NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday </a>

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

GXAI: 105% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/37656829">Gaxos Acquires Rights To AI-Enabled Technology From Top Biohacking App; Terms Not Disclosed</a>
SIGA: 14% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/37650542">SIGA Therapeutics shares are trading higher after the company reported Q4 revenues of $116.5 million, up from $11.4 million year over year.</a>
SKIN: 35% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/37650422">Beauty Health shares are trading higher after the company reported better-than-expected Q4 revenue results.</a>

Market-Moving News for March 13th

WIIM

SIGA Therapeutics shares are trading higher after the company reported Q4 revenues of $116.5 million, up from $11.4 million year over year.

U.S. stock futures were mixed this morning, with the Nasdaq futures falling by around 20 points on Wednesday.
Shares of The Beauty Health Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skin#NASDAQ">SKIN</a>) rose sharply in today&rsquo;s pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/quote/SKIN/earnings">fourth-quarter revenue results</a>.
Beauty Health posted quarterly loss of 7 cents per share, in-line with market estimates. The company&rsquo;s quarterly sales came in at $96.80 million versus expectations of $87.63 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Beauty Health shares jumped 17.3% to $4.21 in pre-market trading.
Here are some big stocks recording gains in today&rsquo;s pre-market trading session.
<ul>
<li>HUTCHMED (China) Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcm#NASDAQ">HCM</a>) shares climbed 15% to $18.78 in pre-market trading after gaining 9% on Tuesday.</li>
<li>SIGA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/siga#NASDAQ">SIGA</a>) gained 13.5% to $6.04 in pre-market trading after the company reported a year-over-year increase in quarterly financial results.</li>
<li>BeiGene, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgne#NASDAQ">BGNE</a>) shares climbed 13% to $185.00 in pre-market trading.</li>
<li>MaxCyte, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mxct#NASDAQ">MXCT</a>) shares gained 10.5% to $4.40 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance.</li>
<li>Full Truck Alliance Co. Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ymm#NYSE">YMM</a>) climbed 10.2% to $7.67 in pre-market trading. Full Truck Alliance announced extension of share repurchase program up to $300 million.</li>
<li>Legend Biotech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/legn#NASDAQ">LEGN</a>) gained 9% to $71.00 in pre-market trading. Raymond James analyst Sean McCutcheon initiated coverage on Legend Biotech with an Outperform rating and announced a price target of $86.</li>
<li>Clover Health Investments, Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clov#NASDAQ">CLOV</a>) climbed 8% to $0.8290 in pre-market trading after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.</li>
<li>United Natural Foods, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unfi#NYSE">UNFI</a>) gained 2.7% to $11.86 in pre-market trading.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37641199/dollar-tree-williams-sonoma-and-3-stocks-to-watch-heading-into-wednesday"> Dollar Tree, Williams-Sonoma And 3 Stocks To Watch Heading Into Wednesday </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Pre-Market Outlook

LEGN

MXCT

UNFI

Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session

SIGA Therapeutics shares are trading higher after the company reported a year-over-year increase in Q4 financial results.

SIGA Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGA#NASDAQ">SIGA</a>) reported quarterly earnings of $1.01 per share. This is a 10200 percent increase over losses of $(0.01) per share from the same period last year. The company reported $116.50 million in sales this quarter. This is a 921.93 percent increase over sales of $11.40 million the same period last year.

Earnings

SIGA Technologies Q4 EPS $1.01 Up From $(0.01) YoY, Sales $116.50M Up From $11.40M YoY

U.S. stocks were higher, with the Dow Jones index surging more than 200 points on Tuesday.
Shares of Bioventus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bvs#NASDAQ">BVS</a>) rose sharply during Tuesday&rsquo;s session after the company reported better-than-expected quarterly financial results and issued FY24 net sales <a href="https://www.benzinga.com/quote/BVS/earnings">guidance above estimates</a>.
Bioventus posted adjusted earnings of 7 cents per share, beating market estimates of 2 cents per share. The company&rsquo;s quarterly sales came in at $135.42 million, versus expectations of $123.96 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Bioventus shares surged 10.8% to $5.88 on Tuesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Ranpak Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pack#NASDAQ">PACK</a>) shares climbed 40.1% to $6.12 after the company reported better-than-expected fourth-quarter revenue results and issued FY24 guidance. Also, Baird maintained an Outperform rating on the stock and raised its price target from $5 to $7.</li>
<li>Nukkleus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nukk#NASDAQ">NUKK</a>) shares gained 22.5% to $1.41 after surging over 43% on Monday.</li>
<li>The Beachbody Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bodi#NYSE">BODI</a>) rose 16.7% to $10.60 after the company reported better-than-expected fourth-quarter revenue results and issued first-quarter revenue guidance.</li>
<li>Kanzhun Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bz#NASDAQ">BZ</a>) climbed 14.8% to $20.10 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance above estimates. The company approved a $200 million share buyback.</li>
<li>Heritage Insurance Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrtg#NYSE">HRTG</a>) shares rose 13.4% to $8.11 following better-than-expected fourth-quarter results.</li>
<li>NuScale Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) surged 12.8% to $6.18.</li>
<li>Mission Produce, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avo#NASDAQ">AVO</a>) gained 12% to $11.98 following upbeat quarterly results.</li>
<li>SIGA Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/siga#NASDAQ">SIGA</a>) surged 11.4% to $5.45 after the company announced a special cash dividend.</li>
<li>Bioventus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bvs#NASDAQ">BVS</a>) climbed 11.2% to $5.91 after the company reported better-than-expected fourth-quarter financial results and issued FY24 net sales guidance above estimates.</li>
<li>GigaCloud Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gct#NASDAQ">GCT</a>) gained 11.1% to $34.27.</li>
<li>Bowman Consulting Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwmn#NASDAQ">BWMN</a>) rose 11% to $37.33 following strong quarterly results.</li>
<li>Oracle Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/orcl#NYSE">ORCL</a>) gained 10.5% to $126.09 after the company reported upbeat earnings for its fiscal third quarter.</li>
<li>Universal Insurance Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uve#NYSE">UVE</a>) rose 10% to $21.57. Universal Insurance announced a new $20 million share repurchase authorization.</li>
<li>Rumble Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rum#NASDAQ">RUM</a>) gained 8.4% to $ 7.24.</li>
<li>Fanhua Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fanh#NASDAQ">FANH</a>) surged 9.3% to $6.02.</li>
<li>Archer-Daniels-Midland Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adm#NYSE">ADM</a>) climbed 5% to $57.63 after the company reported fourth-quarter financial results and issued FY24 guidance. Also, the company authorized the purchase an additional $2 billion of shares under its existing share repurchase program.</li>
<li>MINISO Group Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnso#NASDAQ">MNSO</a>) shares rose 3% to $18.45 after posting stronger-than-expected quarterly earnings.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37605801/how-to-earn-500-a-month-from-nvidia-stock"> How To Earn $500 A Month From NVIDIA Stock </a>

The Beachbody Company, Inc. Class A Common Stock

BODI

BODY

BWMN

FANH

HRTG

MNSO

NUKK

ORCL

PACK

Bioventus Reports Upbeat Earnings, Joins Ranpak, Beachbody And Other Big Stocks Moving Higher On Tuesday

SIGA Technologies shares are trading higher after the company announced a special cash dividend.

Dividends

SIGA Declares Special Cash Dividend of $0.60 Per Share

<h3>Companies Reporting Before The Bell</h3>
&bull; Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) is likely to report earnings for its fourth quarter.
&bull; MINISO Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNSO#NYSE">MNSO</a>) is likely to report quarterly earnings at $0.27 per share on revenue of $530.30 million.
&bull; BioXcel Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTAI#NASDAQ">BTAI</a>) is likely to report quarterly loss at $0.91 per share on revenue of $710 thousand.
&bull; Enfusion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENFN#NYSE">ENFN</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $45.27 million.
&bull; Tupperware Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUP#NYSE">TUP</a>) is estimated to report earnings for its second quarter.
&bull; Kanzhun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) is expected to report quarterly earnings at $0.16 per share on revenue of $214.08 million.
&bull; Manchester United (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) is projected to report quarterly loss at $0.22 per share on revenue of $222.43 million.
&bull; FiscalNote Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $34.53 million.
&bull; Archer-Daniels Midland (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) is projected to report quarterly earnings at $1.43 per share on revenue of $23.64 billion.
&bull; On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $510.19 million.
&bull; Chicago Atlantic Real (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFI#NASDAQ">REFI</a>) is projected to report quarterly earnings at $0.51 per share on revenue of $16.09 million.
&bull; Cormedix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $-250 thousand.
&bull; Kohl&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) is estimated to report quarterly earnings at $1.28 per share on revenue of $5.70 billion.
&bull; PowerFleet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWFL#NASDAQ">PWFL</a>) is likely to report quarterly loss at $0.10 per share on revenue of $34.34 million.
&bull; Lifetime Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCUT#NASDAQ">LCUT</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $197.93 million.
&bull; IHS Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHS#NYSE">IHS</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $476.18 million.
&bull; Bioventus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) is expected to report quarterly earnings at $0.02 per share on revenue of $123.96 million.
&bull; Workhorse Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) is projected to report quarterly loss at $0.09 per share on revenue of $3.24 million.
&bull; Priority Tech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTH#NASDAQ">PRTH</a>) is expected to report quarterly loss at $0.10 per share on revenue of $201.84 million.
&bull; Silence Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>) is estimated to report earnings for its fourth quarter.
&bull; Hagerty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HGTY#NYSE">HGTY</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $245.27 million.
&bull; ATRenew (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) is projected to report earnings for its fourth quarter.
&bull; Core Molding Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CMT#AMEX">CMT</a>) is estimated to report quarterly earnings at $0.06 per share on revenue of $70.75 million.
&bull; Intl Game Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>) is projected to report quarterly earnings at $0.41 per share on revenue of $1.11 billion.
&bull; Blade Air Mobility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>) is projected to report quarterly loss at $0.13 per share on revenue of $48.40 million.
<h3>Companies Reporting After The Bell</h3>
&bull; ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) is projected to report quarterly loss at $0.20 per share on revenue of $6.53 million.
&bull; Guild Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHLD#NYSE">GHLD</a>) is expected to report quarterly earnings at $0.14 per share on revenue of $172.68 million.
&bull; MaxCyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXCT#NASDAQ">MXCT</a>) is likely to report quarterly loss at $0.07 per share on revenue of $13.09 million.
&bull; Natures Sunshine Products (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NATR#NASDAQ">NATR</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $111.13 million.
&bull; Performant Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFMT#NASDAQ">PFMT</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $31.59 million.
&bull; Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) is expected to report quarterly earnings at $0.98 per share on revenue of $592.58 million.
&bull; Arq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQ#NASDAQ">ARQ</a>) is likely to report quarterly loss at $0.08 per share on revenue of $27.00 million.
&bull; Rackspace Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXT#NASDAQ">RXT</a>) is projected to report quarterly loss at $0.04 per share on revenue of $714.72 million.
&bull; Biote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTMD#NASDAQ">BTMD</a>) is likely to report quarterly earnings at $0.08 per share on revenue of $45.74 million.
&bull; Intl General Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGIC#NASDAQ">IGIC</a>) is likely to report earnings for its fourth quarter.
&bull; Champions Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSBR#NASDAQ">CSBR</a>) is projected to report quarterly loss at $0.15 per share on revenue of $13.48 million.
&bull; Aligos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGS#NASDAQ">ALGS</a>) is projected to report quarterly loss at $0.27 per share on revenue of $1.60 million.
&bull; Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $33.52 million.
&bull; Maiden Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHLD#NASDAQ">MHLD</a>) is likely to report earnings for its fourth quarter.
&bull; SIGA Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGA#NASDAQ">SIGA</a>) is likely to report earnings for its fourth quarter.
&bull; Phunware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) is projected to report quarterly loss at $2.00 per share on revenue of $2.10 million.
&bull; Doma Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOMA#NYSE">DOMA</a>) is likely to report quarterly loss at $1.30 per share on revenue of $69.42 million.
&bull; Beauty Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKIN#NASDAQ">SKIN</a>) is projected to report quarterly loss at $0.07 per share on revenue of $87.63 million.
&bull; Laird Superfood (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LSF#AMEX">LSF</a>) is estimated to report quarterly loss at $0.23 per share on revenue of $8.74 million.
&bull; Aterian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>) is projected to report quarterly loss at $0.13 per share on revenue of $29.34 million.
&bull; Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $4.43 million.
&bull; Heron Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRTX#NASDAQ">HRTX</a>) is expected to report quarterly loss at $0.16 per share on revenue of $30.97 million.
&bull; AdTheorent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTH#NASDAQ">ADTH</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $56.20 million.
&bull; Identiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVE#NASDAQ">INVE</a>) is likely to report quarterly loss at $0.03 per share on revenue of $30.00 million.
&bull; Oportun Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRT#NASDAQ">OPRT</a>) is estimated to report quarterly loss at $0.37 per share on revenue of $262.30 million.
&bull; icad (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICAD#NASDAQ">ICAD</a>) is likely to report quarterly loss at $0.05 per share on revenue of $4.30 million.
&bull; Purple Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPL#NASDAQ">PRPL</a>) is expected to report quarterly loss at $0.18 per share on revenue of $145.56 million.
&bull; Quest Resource Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRHC#NASDAQ">QRHC</a>) is projected to report quarterly loss at $0.03 per share on revenue of $73.07 million.
&bull; Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) is likely to report quarterly loss at $1.38 per share on revenue of $1.06 million.
&bull; Transact Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TACT#NASDAQ">TACT</a>) is projected to report quarterly loss at $0.03 per share on revenue of $13.60 million.
&bull; loanDepot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDI#NYSE">LDI</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $236.76 million.
&bull; CryoPort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) is estimated to report quarterly loss at $0.29 per share on revenue of $58.40 million.
&bull; Synchronoss Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCR#NASDAQ">SNCR</a>) is likely to report quarterly loss at $0.10 per share on revenue of $42.84 million.
&bull; Clover Health Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) is estimated to report quarterly loss at $0.14 per share on revenue of $480.25 million.
&bull; Westrock Coffee (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEST#NASDAQ">WEST</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $226.02 million.
&bull; Eastern Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EML#NASDAQ">EML</a>) is likely to report earnings for its fourth quarter.
&bull; BRT Apartments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRT#NYSE">BRT</a>) is estimated to report earnings for its fourth quarter.
&bull; Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) is expected to report quarterly loss at $0.06 per share on revenue of $87.21 million.
&bull; Aware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWRE#NASDAQ">AWRE</a>) is estimated to report earnings for its fourth quarter.
&bull; Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) is likely to report quarterly loss at $0.11 per share on revenue of $151.50 million.
&bull; Allbirds (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIRD#NASDAQ">BIRD</a>) is projected to report quarterly loss at $0.23 per share on revenue of $69.06 million.
&bull; Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $47.25 million.
&bull; PHX Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $9.37 million.
&bull; Veritone (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERI#NASDAQ">VERI</a>) is likely to report quarterly loss at $0.15 per share on revenue of $33.79 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ALGS

AWRE

BLDE

BTAI

BTMD

CLPT

CLSD

CRMD

CSBR

CYRX

DOMA

ENFN

GHLD

HGTY

ICAD

IGIC

INVE

LCUT

MANU

MHLD

NOTE

NRGV

ONON

OPRT

PFMT

PHUN

PRPL

PRTH

PWFL

QFIN

QRHC

REFI

RERE

SNCR

SWIM

TACT

TNON

WEST

WKHS

Earnings Scheduled For March 12, 2024

Health Care

Management

SIGA Technologies Announced That Diem Nguyen Will Join The Company As Chief Executive Officer, Effective January 27, And Will Also Be Appointed To The Company's Board Of Directors. Siga's Current CEO, Phil Gomez, Will Retire From SIGA On January 26

<a href="https://www.reuters.com/business/healthcare-pharmaceuticals/who-very-worried-about-spread-mpox-drc-2023-12-08/?taid=65734f21df0b0e0001648213&amp;utm_campaign=trueanthem&amp;utm_medium=trueanthem&amp;utm_source=twitter">https://www.reuters.com/business/healthcare-pharmaceuticals/who-very-worried-about-spread-mpox-drc-2023-12-08/?taid=65734f21df0b0e0001648213&amp;utm_campaign=trueanthem&amp;utm_medium=trueanthem&amp;utm_source=twitter</a>
The World Health Organization is "very worried" about the spread of a severe form of mpox that has killed nearly 600 people, mainly children, in the Democratic Republic of Congo this year, a senior official said.
The country has reported over 13,000 cases in 2023, more than twice as many as during the last peak in 2020, with the disease occurring in almost every province. The WHO is working with the authorities on the response and a risk assessment.
On Thursday, the U.S. Centers for Disease Control and Prevention (CDC) <a href="https://www.reuters.com/world/africa/us-cdc-issues-health-alert-subtype-mpox-virus-congo-2023-12-07/">issued an alert</a> about the dangerous clade I mpox outbreak.
"The virus variant is known to be more virulent. If it adapts better to human to human transmission, that presents a risk," Rosamund Lewis, WHO's mpox lead, told Reuters by phone from Kinshasa.
Mpox is a viral infection that spreads through close contact, causing flu-like symptoms and pus-filled lesions. Most cases are mild but it can kill.
Last year, a less severe form – clade II – began to spread globally, largely through sexual contact among men who have sex with men, and the WHO declared a public health emergency.
New evidence that clade I can also spread through sexual contact is concerning, Lewis said. Mpox can also spread to humans from infected animals or among family members within households, she said. Children and people with weak immune systems are more at risk, with illness leading to death in up to 10% of clade I cases.
"We have very little information of who is dying of mpox [in DRC] other than age," said Lewis, adding more data was needed.
The WHO is also worried about an outbreak among sex workers in South Kivu, because of the vulnerability of the population as well as the risk of the infection spreading to neighbouring countries, she said.
The agency is working with the Congo government to resolve <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/stigma-regulatory-barriers-delay-mpox-response-country-that-needs-it-most-2023-12-05/">regulatory</a> hurdles to enable the country to procure or accept donations of mpox vaccines, currently only available in the country in ongoing clinical studies. There is also a mpox antiviral treatment trial underway.
DRC has not requested any treatments, Lewis said. Getting the vaccine is more complex, she added, because only one region of the WHO has a supply agreement in place. Any donations would also need funding for deployment.

Reported Earlier, "WHO 'Very Worried' About Spread Of Mpox In DRC" - Reuters News

SIGA Technologies Q3 2023 EPS $(0.01) Down From $0.45 YoY, Revenue $9.2M Down From $72.2M YoY